POST GENOME INST CO LTD has a total of 29 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), Japan and Canada. Its main competitors in its focus markets biotechnology and pharmaceuticals are GENECOPOEIA INC, NOVAGEN INC and YOKOYAMA SHIGEYUKI.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Japan | 4 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | China | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | United States | 2 | |
#9 | Australia | 1 | |
#10 | Iceland | 1 | |
#11 | Mexico | 1 | |
#12 | Norway | 1 | |
#13 | Slovakia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Fermentation | |
#2 | Microorganisms | |
#3 | Measuring microorganism processes | |
#4 | Peptides | |
#5 | Medical preparations | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Inoue Akio | 9 |
#2 | Ueda Takuya | 8 |
#3 | Matsushima Kouji | 8 |
#4 | Shimizu Yoshihiro | 8 |
#5 | Sugano Sumio | 6 |
#6 | Hashimoto Shin-Ichi | 5 |
#7 | Kuwata Hidefumi | 4 |
#8 | Sameshima Yukie | 3 |
#9 | Kidokoro Minoru | 2 |
#10 | Kohara Michinori | 2 |
Publication | Filing date | Title |
---|---|---|
WO2007058376A1 | Method for efficient synthesis of protein having labeled n-terminal amino acid residue | |
JP2007028923A | Method for producing single strand gene tag group containing transcription starting site | |
JP2006340694A | Method for synthesizing protein by in vitro transcription/translation system using molecular chaperone | |
CA2564831A1 | Method of forming disulfide crosslink in in vitro protein synthesis | |
CN1914318A | Method of obtaining gene tag | |
JP2005185269A | Method for acquiring gene tag | |
SK10862002A3 | Process for producing peptides by using in vitrotranscription/translation system | |
JP2003102495A | Method of producing peptide or the like via in vitro transcription-translation system |